Clinical Pharmacology · Diabetes Medications
Insulins
On this page 7 sections
In 30 seconds
Insulin is the hormone that lets glucose move out of the blood and into cells, and every diabetes patient who cannot make or use enough of it eventually needs it replaced. Different insulin products are classified by how fast they start working, when they peak, and how long they last, which determines whether they cover a meal, act as background coverage, or handle an emergency. Nursing care around insulin is dominated by administration precision and hypoglycemia recognition, because it is a high-alert medication where a dosing or timing error causes real harm. Understanding the basal-bolus concept ties all the insulin types together into how real regimens are built.
The college version
What insulin does in the body
Insulin is produced by beta cells of the pancreas and is the primary hormone that lowers blood glucose. It binds insulin receptors on muscle and fat cells, triggering glucose transporters to move to the cell surface so glucose can leave the bloodstream and enter the cell to be used or stored. In the liver, insulin suppresses gluconeogenesis and glycogen breakdown, reducing the amount of new glucose the liver releases. Insulin is also anabolic in a broader sense: it promotes fat storage, drives protein synthesis, and shifts potassium into cells by stimulating the sodium-potassium pump, which is why insulin is used therapeutically to treat dangerously elevated potassium levels even in people without diabetes. When insulin is deficient or ineffective, as in type 1 or advanced type 2 diabetes, glucose stays in the blood, the liver keeps producing more, and cells are starved of fuel despite a glucose surplus.
Classification by time-action profile
Insulin products are grouped by onset, peak, and duration rather than by chemical novelty alone.
- Rapid-acting analogues (lispro, aspart, glulisine) are engineered so they are absorbed quickly and clear quickly, making them ideal for covering the glucose rise from a meal when given close to eating.
- Short-acting regular insulin generally has a slower onset and longer duration than rapid-acting analogues. Intravenous use depends on the exact product and concentration: HUMULIN R U-100 and HUMALOG U-100 have labeled intravenous uses under medical supervision, whereas HUMULIN R U-500 and HUMALOG U-200 do not. The product's current prescribing information and the institution's protocol govern administration; this explanation is not an administration guide.
- Intermediate-acting NPH has a cloudy suspension appearance, an onset and duration between rapid and long-acting products, and a distinct peak that must be anticipated when planning meals and monitoring.
- Long-acting basal analogues (glargine, detemir, degludec) provide background coverage with a less pronounced peak than NPH. Their timing and duration vary by product, dose, and individual; a simplified classification does not establish a dosing schedule.
- Premixed products combine a rapid- or short-acting component with an intermediate-acting component in a fixed ratio, simplifying dosing for patients who need both mealtime and background coverage but cannot manage separate injections.
Basal-bolus therapy and technology
Physiologic insulin replacement mimics how a healthy pancreas works: a steady basal level suppresses hepatic glucose output between meals and overnight, while bolus doses cover the glucose load from food and correct unexpected highs. Bolus dosing conceptually has two components: a carbohydrate ratio that estimates how much insulin is needed per amount of carbohydrate eaten, and a correction factor that adds extra insulin when the pre-meal reading is above target. This basal-bolus approach better matches natural physiology than older fixed-dose regimens. Insulin pumps deliver rapid-acting insulin continuously as programmed basal rates plus patient-activated bolus doses, eliminating the need for separate long-acting injections. Continuous glucose monitors track interstitial glucose in real time and, paired with a pump, can adjust or suspend delivery automatically, reducing both highs and dangerous lows.
Administration essentials
Insulin is a high-alert medication, and administration technique is a major focus of nursing education. Injection-site rotation helps reduce lipodystrophy and localized cutaneous amyloidosis; the current product instructions identify appropriate sites and technique. Mixing permissions are product-specific. HUMULIN R U-100 labeling permits mixing only with HUMULIN N and specifies drawing HUMULIN R into the syringe first. That permission does not apply to HUMULIN R U-500, which must not be mixed or diluted. LANTUS (insulin glargine) must not be mixed or diluted with another insulin or solution, or given intravenously. These examples do not authorize someone to combine prescribed products independently. Preparation, device handling, storage, in-use discard times, and monitoring must follow the exact product's current labeling and an individualized clinician-directed plan. A basal-bolus regimen uses complementary prescribed insulins; it does not imply that they may be mixed in one syringe.
Hypoglycemia and other adverse effects
Hypoglycemia is a major and potentially life-threatening adverse effect of insulin therapy. Warning signs can include shakiness, sweating, palpitations, anxiety, confusion, slurred speech, or blurred vision; severe episodes can cause seizure or loss of consciousness. Symptoms vary and may be less apparent with some medicines, including beta blockers. Recognition and treatment require the person's clinician-directed hypoglycemia plan; this lesson is not an emergency treatment protocol. Other notable effects include weight gain and hypokalemia, with monitoring particularly important during intravenous use. High morning glucose can have several causes. A morning reading alone does not establish the overnight glucose pattern or justify changing the evening dose. Clinicians assess glucose trends and the person's regimen before making individualized changes, with increased monitoring when treatment changes.
Sick days and changing insulin needs
During illness, insulin needs typically rise because stress hormones raise blood glucose even when oral intake drops, so patients are taught never to stop insulin entirely during sick days without guidance, to monitor more frequently, and to stay hydrated. Corticosteroid use similarly raises blood glucose and often requires a temporary increase in insulin. Exercise increases insulin sensitivity and glucose uptake by muscle, which can lower insulin needs or increase hypoglycemia risk around activity. Pregnancy alters insulin requirements substantially as placental hormones increase insulin resistance as gestation progresses, requiring ongoing dose adjustment and close monitoring.

Eli explains
The same idea, in plain words
Explain it like I’m 10
Think of insulin as a key that helps sugar move from your blood into muscle and fat cells to be used for energy. Different prescribed insulin products work on different schedules: some provide mealtime coverage and some provide background coverage. A clinician may prescribe both, like steady background light plus extra light when it is needed. Using both in a treatment plan does not mean mixing them together in a syringe. The exact product, concentration, device, and route matter. Too much insulin can dangerously lower blood sugar, so people need an individualized treatment and safety plan from their healthcare team, not instructions from a study lesson.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient on a long-acting basal insulin and metoprolol (a beta blocker) has a hypoglycemic episode overnight but reports feeling almost nothing beforehand. Explain why the beta blocker may be responsible.
Show answer
Beta blockers blunt the autonomic warning signs of hypoglycemia
Beta blockers can make some warning signs of hypoglycemia less apparent. The absence of a familiar warning feeling does not exclude low blood glucose. Insulin labeling calls for appropriate glucose monitoring and recognizes medicines that can blunt symptoms; the person's healthcare team should assess their individual risk and monitoring plan.
Why is one high morning blood glucose reading insufficient for deciding to change an evening insulin dose, and who should assess a possible regimen change?
Show answer
Glucose trends and an individualized clinical assessment are needed
A single morning value does not reveal what happened overnight or explain why it happened. The clinician should assess glucose trends, the prescribed regimen, and the person's circumstances before recommending a change, with appropriate monitoring. This lesson does not direct anyone to raise, lower, or stop insulin.
Quick check
3 questions here. Answers stay hidden until you check.
When a prescribed regimen and current product labeling permit mixing HUMULIN R U-100 with HUMULIN N, which product is drawn into the syringe first?
Why does LANTUS labeling prohibit mixing or diluting it with another insulin or solution?
Study tools & related lessonsRelated
Sources & references
- DailyMed: HUMULIN R U-100 prescribing information — sections 2.2 and 2.5 (intravenous use and mixing)
- DailyMed: HUMALOG prescribing information — sections 2.2, 5.2, and 7 (U-100/U-200 routes, regimen changes, and symptoms)
- DailyMed: HUMULIN R U-500 prescribing information — section 2.1 (no intravenous use, mixing, or dilution)
- DailyMed: LANTUS prescribing information — section 2.1 (subcutaneous route, no mixing or dilution)
- DailyMed: HUMULIN N prescribing information — section 2.1 (subcutaneous suspension, no intravenous use)
These are the references recorded for this imported study material. Where available, recorded source rights are shown above; source links alone do not establish permission to reuse protected material. Licenses may differ by publication and version. See Copyright & Licensing.
Health education for study only, not individualized medical advice. Do not use this material to diagnose, prescribe, or administer treatment. Check current professional references and your institution’s protocols. Educational Disclaimer.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.

